Interleukin-6 serum levels in metastatic breast cancer and non-metastatic breast cancer
Keywords:
breast cancer, interleukin-6, metastasesAbstract
Introduction: This study has investigated the correlation between IL-6 serum levels with distant metastatic breast cancer incidence. Methods: We recruited female breast cancer patients at Dr. Soetomo General Hospital from March until May 2022. The sample was divided into 2 groups that consist Metastatic Breast Cancer (MBC) and non-MBC. After the stage, the IL-6 serum levels were measured. The study design was an observational analytic study, comparative analytics by comparing IL-6 serums levels in both groups: MBC and non-MBC. Results: Sixty patients, with the Non-Specific type being the common histopathology type found in this study (85%). We found 29 patients with metastases and 31 patients without metastases. Overall analyses identify Patient with high IL-6 serum levels had a 2.54 times higher chance of having a metastasis than patients with low IL-6 serum levels (95% CI = 1.39-4.63). Conclusions: Subjects with IL-6 serum levels >15.495 pg/mL had a higher risk for incidence of metastatic. The IL-6 serum levels may be a potential biomarker to predict metastases in breast cancer patients.
Downloads
References
Borst MJ, Ingold JA. Metastatic patterns of invasive lobular versus invasive ductal carcinoma of the breast. Surgery. 1993 Oct;114(4):637-41; discussion 641-2. PMID: 8211676
Breast Cancer Health Center. Breast cancer in young women [downloaded 8 Maret 2022]. Available from: http://www.webmd.com/ breast-cancer/guide/breast-cancer-young- women.
Devi, D. G. A. P., Purwanto, H., & Sandhika, W. (2021). Changes in Ki67 expression and clinical response to neoadjuvant chemotherapy in locally advanced breast cancer (LABC). Bali Medical Journal, 10(3), 925–931. https://doi.org/10.15562/bmj.v10i3.2700
Dewi, D. C., & Sudiana, I. K. (2017). EFFECT OF Cayratia trifolia L (Domin) EXTRACT ON REDUCED EXPRESSION OF MATRIX METALLOPROTEINASE-9 (MMP–9) AND VASCULAR ENDOTHELIAL GROWTH FACTOR –A (VEGF-A) IN WHITE RATS WITH BREAST CANCER. Folia Medica Indonesiana, 52(1), 35–41. https://doi.org/10.20473/fmi.v52i1.5206
Dewi Maryam1, Iskandar Ali1. (2020). Influence of BRACA Usage on Self Improvement of Breast Cancer Patient by Post Mastectomy. Indian Journal of Forensic Medicine & Toxicology, 14(2), 2233–2236. https://doi.org/10.37506/ijfmt.v14i2.3350
Dewi TK. Validation of the Indonesian version of Champion’s Health Belief Model Scale for breast self-examination. Psychol Res Behav Manag. 2018;11:433-438
https://doi.org/10.2147/PRBM.S177124
Gaili A, Fang W, Shangke H, Lu F, Jun B, Shanzhi G, Xinhan Z (2019) Effects of CCL5 on the biological behavior of breast cancer and the mechanisms of its interaction with tumor-associated macrophages. Oncol Rep. 2019 Dec; 42(6): 2499–2511. Published online 2019 Oct 1. doi: 10.3892/or.2019.7344
Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells. Clin Cancer Res. 2006 Jan 1;12(1):11-9. doi: 10.1158/1078-0432.CCR-04-1752. PMID: 16397018.
Hadisuwarno W. et al (2021) A 40-year-old Woman with Hypercalcemia Crisis Caused by Bone Metastasis in Stage IV Breast Cancer. Biomolecular and Health Science Journal, 2021 October, Vol.04 (02). DOI: 10.20473/bhsj.v4i2.29633
Hyuna S, Jacques F, Rebecca S, Mathieu L, Isabelle S, Ahmedin J, Freddie B (2021). Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians / Volume 71, Issue 3 / p. 209-248. doi.org/10.3322/caac.21660
Ji, Y., Wang, H. Prognostic prediction of systemic immune-inflammation index for patients with gynecological and breast cancers: a meta-analysis. World J Surg Onc 18, 197 (2020). https://doi.org/10.1186/s12957-020-01974-w
Kim MY, Oskarsson T, Acharyya S, Nguyen DX, Zhang XH, Norton L, Massagué J. Tumor self-seeding by circulating cancer cells. Cell. 2009 Dec 24;139(7):1315-26. doi: 10.1016/j.cell.2009.11.025. PMID: 20064377; PMCID: PMC2810531.
Kishimoto, Tadamitsu. “Interleukin-6: discovery of a pleiotropic cytokine.” Arthritis research & therapy vol. 8 Suppl 2,Suppl 2 (2006): S2. doi:10.1186/ar1916
Kozłowski L, Zakrzewska I, Tokajuk P, Wojtukiewicz MZ. Concentration of interleukin-6 (IL-6), interleukin-8 (IL-8) and interleukin-10 (IL-10) in blood serum of breast cancer patients. Rocz Akad Med Bialymst. 2003;48:82-4. PMID: 14737948.
Pratama FM, Ghaib H, Ali I. Correlation between serum interleukin-6 levels and clinical response to anthracyclinebased neoadjuvant chemotherapy regimen in locally advanced breast cancer patients. International Journal of Research and Review. 2021; 8(11): 1-9. DOI: https://doi.org/10.52403 /ijrr.20211101
Ravishankaran, Praveen, and R Karunanithi. “Clinical significance of preoperative serum interleukin-6 and C-reactive protein level in breast cancer patients.” World journal of surgical oncology vol. 9 18. 6 Feb. 2011, doi:10.1186/1477-7819-9-18
Siegel RL, Miller KD, Jemal A. (2016) Cancer statistics. CA Cancer J Clin. 2016;66(1):7–30. Epub 2016/01/09. pmid:26742998
Xiao W, Zheng S, Yang A, Zhang X, Zou Y, Tang H, Xie X. Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study. Cancer Manag Res. 2018;10:5329-5338
https://doi.org/10.2147/CMAR.S176763
Yang C, Lei C, Zhang Y, Zhang J, Ji F, Pan W, Zhang L, Gao H, Yang M, Li J and Wang K (2020) Comparison of Overall Survival Between Invasive Lobular Breast Carcinoma and Invasive Ductal Breast Carcinoma: A Propensity Score Matching Study Based on SEER Database.Front. Oncol. 10:590643. doi: 10.3389/fonc.2020.590643
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). The COVID-19 pandemic. International Journal of Health Sciences, 5(2), vi-ix. https://doi.org/10.53730/ijhs.v5n2.2937
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
